Clinical Research Directory
Browse clinical research sites, groups, and studies.
Breast Cancer Plasma Adjuvant Intra-operative Treatment (Breast Cancer PAINT)
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Summary
The goal of this clinical trial is to test the safety of the use of non-thermal plasma (NTP, an ionized gas) on the tumor bed after the removal of the tumor in breast cancer patients. The main questions it aims to answer are: * To determine the safe and tolerable dose of NTP in patients with breast cancer; * To assess the safety and tolerability of NTP; * To assess the cosmetic effects of NTP treatment in patients with breast cancer. Participants will receive one treatment of the tumor bed after the removal of their breast tumor.
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2024-09
Completion Date
2026-01
Last Updated
2024-06-27
Healthy Volunteers
No
Conditions
Interventions
Convertible Plasma Jet
NTP will be applied to the patients using the Convertible Plasma Jet (CPJ, NexPlasmaGen Inc.)
Locations (1)
Centre Hospitalier de l'Université de Montréal - CHUM
Montreal, Quebec, Canada